NASDAQ: TARS - Tarsus Pharmaceuticals, Inc.

Rentabilidade por seis meses: +99.36%
Setor: Healthcare

Cronograma de promoção Tarsus Pharmaceuticals, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa

Tarsus Pharmaceuticals, Inc., биофармацевтическая компания на клинической стадии, специализируется на разработке и коммерциализации новых терапевтических кандидатов для офтальмологических состояний. Его ведущим кандидатом в продукт является TP-03, новый терапевтический препарат, который находится в фазе IIb / III для лечения блефарита, вызванного заражением клещами Demodex, а также для лечения болезни мейбомиевых желез. Компания также разрабатывает TP-04 для лечения купероза; и TP-05 для профилактики Лайма и снижения заболеваемости малярией. Tarsus Pharmaceuticals, Inc.

Mais detalhes
была зарегистрирована в 2016 году, ее штаб-квартира находится в Ирвине, Калифорния.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

EBITDA -0.0039
EV/EBITDA 14.7
IPO date 2020-10-16
ISIN US87650L1035
Industry Pharmaceuticals
P/BV 5.06
P/S 25.12
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.0334
Сайт http://www.tarsusrx.com
Цена ао 47.3
Число акций ао 0.02938 млрд
Alteração de preço por dia: 0% (52.7)
Alteração de preço por semana: +3.17% (51.08)
Alteração de preço por mês: +12.39% (46.89)
Alteração de preço em 3 meses: +52.31% (34.6)
Mudança de preço em seis meses: +99.36% (26.435)
Mudança de preço por ano: +162.19% (20.1)
Mudança de preço em 3 anos: +104.66% (25.75)
Mudança de preço desde o início do ano: +160.25% (20.25)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 33.95 1
P/BV 3.01 5
P/E 0 0
EV/EBITDA -2.81 0
Total: 4

Eficiência

Nome Significado Nota
ROA, % -51.04 0
ROE, % -68.99 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.2124 10
Total: 7.6

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % -47.76 0
Rentabilidade Ebitda, % 3276.15 10
Rentabilidade EPS, % 133.58 10
Total: 8
Mais detalhes

Instituições Volume Compartilhar, %
RTW Investments LP 3152341 9.21
Blackrock Inc. 2516139 7.35
Cormorant Asset Management, LP 2221422 6.49
Tang Capital Management, LLC 2204797 6.44
Morgan Stanley 1957688 5.72
COWEN AND COMPANY, LLC 1911399 5.59
Frazier Life Sciences Management, L.P. 1787527 5.22
Vivo Capital, LLC 1784006 5.21
Vanguard Group Inc 1595501 4.66
Perceptive Advisors LLC 1296416 3.79

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
First Trust Active Factor Small Cap ETF 0.14858 34.251150665961 1.61948
Virtus LifeSci Biotech Products ETF 1.51269 36.788704846892 0.13953
ProShares Ultra Nasdaq Biotechnology 0.08178 51.697637072723 0.85651
Dimensional U.S. Core Equity 2 ETF 0.00563 30.755198832543 1.47098
Dimensional US Core Equity Market ETF 0.00167 30.983243755928 1.40618
Dimensional U.S. Equity ETF 0.00083 31.530984204131 1.3557
iShares ESG Aware MSCI USA Small-Cap ETF 0.06317 29.190260475651 1.49366
Fidelity MSCI Health Care Index ETF 0.01274 11.599806669889 1.46057
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.05832 31.359936575053 1.41955
ProShares Hedge Replication ETF 0.00736 5.9237999659878 1.47892
Humankind US Stock ETF 0.00863 18.809430395549 1.99919
Invesco Nasdaq Biotechnology ETF 0.12596 28.578975171685 0.8565
iShares U.S. Pharmaceuticals ETF 0.46183 15.607863800409 1.97922
iShares Morningstar Small-Cap ETF 0.01793 30.095066471445 1.60498
iShares Morningstar Small-Cap Growth ETF 0.02659 33.628071953382 0.72598
iShares Morningstar Small Cap Value ETF 0.00907 26.701717953559 2.50476
iShares Micro-Cap ETF 0.3219 29.340359461748 1.54048
iShares Russell 2000 Growth ETF 0.09423 38.042556988 0.6026
iShares Russell 3000 ETF 0.00227 30.952834139099 1.43482
iShares Morningstar Small-Cap ETF 0.01793 391.25300933451 1.60498
iShares Morningstar Small-Cap Growth ETF 0.02659 680.05582339508 0.72598
iShares Morningstar Small-Cap Value ETF 0.00907 213.164717614 2.50476
Nuveen ESG Small-Cap ETF 0.08932 25.458025704129 1.41019
Direxion Daily Pharmaceutical & Medical Bull 3X Shares 1.64161 86.715867158672 1.2989
Schwab U.S. Small-Cap ETF 0.02574 29.67032967033 1.51433
Schwab U.S. Broad Market ETF 0.00173 31.504006586479 1.43354
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.06495 27.374784110535 1.66828
ProShares UltraPro Russell2000 0.02743 89.821266282945 1.47873
Vanguard U.S. Momentum Factor ETF 0.1 45.845704753962 1.05834
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.07 35.148104265403 0.60264
Vanguard Russell 2000 ETF 0.04 30.781541744465 1.48801
SPDR S&P Pharmaceuticals ETF 2.07046 29.798803697662 1.29889
Principal Healthcare Innovators ETF 0.12645 618.4964157054 0.8416
Future Tech ETF 0.12645 426.33969118983 0.8416



Supervisor Cargo Pagamento Ano de nascimento
Dr. Bobak R. Azamian M.D. Co-Founder, President, CEO & Chairman 962.08k
Dr. Seshadri Neervannan Ph.D. Chief Operating Officer 486.67k 1968 (56 anos)
Dr. Bryan Wahl J.D., M.D. General Counsel & Corporate Secretary 619.09k 1978 (46 anos)
Mr. David Nakasone Head of Investor Relations N/A
Mr. Matthew Rossen M.B.A. Vice President of Marketing N/A 1978 (46 anos)
Dr. Elizabeth Yeu Lin M.D. Chief Medical Advisor & Director 286k 1978 (46 anos)
Ms. Adrienne Kemp Senior Director of Corporate Communications N/A
Mr. Jeffrey S. Farrow CFO & Chief Strategy Officer N/A 1962 (62 ano)
Mr. Scott Youmans Vice President of Sales N/A
Ms. Dianne C. Whitfield M.S.W. Chief Human Resources Officer 578.9k 1977 (47 anos)

Endereço: United States, Irvine, CA , 15440 Laguna Canyon Road - abrir no Google Maps, abrir mapas Yandex
Site: http://www.tarsusrx.com